We took advantage of the publicly available databases to evaluate whether ABCB1 and ABCG2 genes were altered, by mutation or amplification, in CNS tumors, glioblastoma and medulloblastoma (the most common pediatric CNS tumor- will be described in details later). This evidence concerns the gene ABCB1 and medulloblastoma.